Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
158.08B
Market cap158.08B
Price-Earnings ratio
36.71
Price-Earnings ratio36.71
Dividend yield
6.20%
Dividend yield6.20%
Average volume
32.07M
Average volume32.07M
High today
$28.19
High today$28.19
Low today
$27.53
Low today$27.53
Open price
$28.08
Open price$28.08
Volume
28.54M
Volume28.54M
52 Week high
$29.21
52 Week high$29.21
52 Week low
$23.58
52 Week low$23.58

Stock Snapshot

The current Pfizer(PFE) stock price is $27.53, with a market capitalization of 158.08B. The stock trades at a price-to-earnings (P/E) ratio of 36.71 and offers a dividend yield of 6.20%.

On 2026-09-14, Pfizer(PFE) stock traded between a low of $27.53 and a high of $28.19. Shares are currently priced at $27.53, which is 0.0% above the low and -2.3% below the high.

The Pfizer(PFE)'s current trading volume is 28.54M, compared to an average daily volume of 32.07M.

In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.58.

In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.58.

PFE News

Nasdaq 2h
Blackrock Moves Up In Market Cap Rank, Passing Pfizer

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Blackrock Inc (Symbol: BLK) has taken over the #77 spot...

Blackrock Moves Up In Market Cap Rank, Passing Pfizer
24/7 Wall St. 9h
Pfizer's 6% Yield Masks a Fragile Dividend Story

Investing Pfizer’s 6% Yield Masks a Fragile Dividend Story Pfizer's payout looks like a safe harbor in a rough market, but the patent clock is ticking and the b...

Pfizer's 6% Yield Masks a Fragile Dividend Story
TipRanks 22h
Pfizer aims at air-traffic controllers for Covid-19 vaccine money, WSJ says

In an attempt to get paid for millions of unwanted Covid-19 vaccines, Pfizer (PFE) is taking aim at air-traffic controllers, Benjamin Katz of The Wall Street Jo...

Analyst ratings

61%

of 28 ratings
Buy
32.1%
Hold
60.7%
Sell
7.1%

More PFE News

The Wall Street Journal 1d
Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines

Polish and Romanian regulators say Pfizer’s move could jeopardize air safety. Mateusz Wlodarczyk / NurPhoto / Getty Images Pfizer PFE 0.25 %increase; up pointi...

Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines
Nasdaq 2d
How Concerned Should Income Investors Be About Pfizer's Dividend?

Key Points Pfizer is one of the world's best-known drug companies, offering a well-above-market dividend yield. The company is facing typical industry headwin...

How Concerned Should Income Investors Be About Pfizer's Dividend?
TipRanks 2d
Pfizer Stock Eyes New Boom With Obesity And Alopecia Bets

Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. (PFE) is stepping up its post‑COVID grow...

24/7 Wall St. 3d
The Dividend Stocks That Generate $6,400 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)

Investing The Dividend Stocks That Generate $6,400 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account) Holding high-yield dividend stocks like...

The Dividend Stocks That Generate $6,400 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)
TipRanks 4d
Pfizer Advances Alopecia Areata Drug Ritlecitinib in Key Phase 3 Trial

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a Phase 3 study called “A PHASE 3, RANDOMIZED, DOUBLE BLIND,...

TipRanks 5d
Pfizer price target raised to $30 from $28 at HSBC

HSBC raised the firm’s price target on Pfizer (PFE) to $30 from $28 and keeps a Hold rating on the shares. The firm adjusted targets in the healthcare group to...

Nasdaq 5d
Pfizer Stock Rises Almost 9% in 3 Months: Time to Buy, Hold or Exit?

Pfizer PFE stock has risen 8.6% in the past three months as investors have gained confidence in the company’s ability to stabilize earnings and offset the conti...

Pfizer Stock Rises Almost 9% in 3 Months: Time to Buy, Hold or Exit?

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.